NewslettersPancreatic Cell NewsUncategorizedProtoKinetix Announces the Resumption of Phase Ib Clinical Trials for the use of AAGP® Treated Islet Cells in the Treatment of Type 1 DiabetesBy Justin.choi - April 27, 202108ProtoKinetix announced Phase I clinical trials of AAGP® treated islet cells have resumed at the University of Alberta, Edmonton.[ProtoKinetix, Inc. (Business Wire)] 7753456 {7753456:nan} apa 50 1 161598 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/Press Release